VO2drépano: VO2max & HRQoL in Children With Sickle Cell Disease

Sponsor
University Hospital, Montpellier (Other)
Overall Status
Completed
CT.gov ID
NCT05995743
Collaborator
(none)
72
1
12
6

Study Details

Study Description

Brief Summary

Sickle cell disease is the most common inherited genetic disorder, accounting for 300,000 births worldwide per year. It is caused by an autosomal recessive mutation of the β-globin gene, responsible for an abnormal hemoglobin, the main protein in red blood cells, responsible for transporting oxygen from the lungs to the tissues. The abnormal hemoglobin, known as "Sickle" or S, deforms the red blood cell, causing chronic hemolytic anemia, organ damage (heart, spleen, etc.) and vaso-occlusive crises. Therapeutic progress and specialised patient follow-up have considerably improved the vital and functional prognosis of children and adolescents with sickle cell disease. Physical fitness, measured during a cardiorespiratory exercise test (CPET), is used to determine maximal oxygen uptake (VO2max). Patients with sickle cell disease have a multifactorial limitation of exercise tolerance, which may affect their physical fitness. Authors have shown that VO2max is impaired in children and adolescents with sickle cell disease, independently of their baseline hemoglobin level. Yet VO2max is a key determinant of health-related quality of life (HRQoL) in patients being monitored for a chronic disease. In the past, our team has contributed to the assessment of HRQoL in several groups of pediatric patients suffering from chronic disease (congenital heart disease, PAH). To date, the link between impaired physical fitness and HRQoL has not been demonstrated in sickle cell children. The pathophysiological determinants of reduced physical capacity and exercise tolerance in sickle cell patients have also not been fully elucidated. Studying these factors will enable us to propose appropriate treatment in the future, with the aim of improving physical fitness and HRQoL in children and adolescents with sickle cell disease.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    This prospective case-control study included sickle cell children and healthy controls from 6 to 17 years old. Patients refuse the use of medical data will be excluded.

    After description of the study sample, we will first compare the VO2max Z-score between cases and controls. We will correlate the VO2max to PedsQL self- and proxy-related and Ricci and Gagnon scores (use of the coefficient of correlation rhô). Then we will compare others CPET parameters and will determine associated factors of VO2max with others resting data : hematological, respiratory, cardiologic, anthropometric, educational (use of the coefficient of correlation rhô, and multivariate linear regression model).

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    72 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Cross-Sectional
    Official Title:
    Aerobic Physical Fitness and Health-related Quality of Life in Children With Sickle Cell Disease.
    Actual Study Start Date :
    Nov 1, 2021
    Actual Primary Completion Date :
    Nov 1, 2022
    Actual Study Completion Date :
    Nov 1, 2022

    Arms and Interventions

    Arm Intervention/Treatment
    Cases: Children with sickle cell disease

    Children aged 6 to 17 years with a confirmed diagnosis of sickle cell disease (i.e., homozygous HbS/S or heterozygous HbS/C mutations)

    Controls: Healthy children referred for a non-severe functional symptom linked to exercise

    Children aged 6 to 17 years with a completely normal check-up, including physical examination, ECG, echocardiography, and spirometry. Children with any chronic disease, medical condition, or medical treatment and those requiring any further specialized medical consultation were not eligible.

    Outcome Measures

    Primary Outcome Measures

    1. Difference between aerobic fitness evaluated by VO2max, expressed in Z-score between cases and controls [1 day]

    Secondary Outcome Measures

    1. Correlation between aerobic fitness and quality of life in cases group [1 day]

      To analyze this, we will correlate the VO2max Z-score and the assessment of health-related quality of life (measured by PedQL 4.0).

    2. Correlation between aerobic fitness and physical activity level, in cases group [1 day]

      To analyze this, we will correlate the VO2max Z-score and the assessment of physical activity level (measured by Ricci and Gagnon questionnaire).

    3. Correlation between aerobic fitness and educational level (knowledge about disease), in cases group [1 day]

      To analyze this, we will correlate the VO2max Z-score and the assessment of educational level (local disease knowledge questionnaire).

    4. Correlation between aerobic fitness and VO2max limiting factors in cases group: demographic, genetic mutation, clinical (comorbidities, respiratory function, cardiac function, anemia, CPET data) [1 day]

      To analyze this, we will correlate the VO2max Z-score and demographic data, genetic mutation, spirometry, plethysmography, trans-thoracic echocardiography, hemoglobin level, other CPET data.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    6 Years to 17 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No

    Sickle cell children

    Inclusion Criteria:
    • Child from 6 to 17 years old, with a confirmed diagnosis of sickle cell disease (i.e., homozygous HbS/S or heterozygous HbS/C mutations), during their routine follow-up, having performed :

    • a hematology consultation : physical examination, blood test

    • a cardiology consultation : electrocardiogram, transthoracic echocardiography

    • a respiratory plethysmography

    • a CPET and to fill in the study questionnaires.

    Exclusion Criteria:
    • Parents' refusal to use medical data.

    Healthy children

    Inclusion Criteria:
    • Child from 6 to 17 years old having performed a cardio-respiratory exercise test for chest pain, dyspnea on exertion, heart murmur and whose results do not find:

    • Congenital heart disease (normal echocardiography and ECG)

    • Respiratory disease (normal FEV1 and FVC)

    • Child having performed a maximal cardio-respiratory stress exercise until exhaustion.

    Exclusion Criteria:
    • Child taking long-term drug treatment

    • Child with chronic disease

    • Parents' refusal to use medical data.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Pediatric and Congenital Cardiology Department, Arnaud De Villeneuve University Hospital Montpellier Occitanie France 34295

    Sponsors and Collaborators

    • University Hospital, Montpellier

    Investigators

    • Principal Investigator: Corentin Laurent-Lacroix, Resident, Montpellier University Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    University Hospital, Montpellier
    ClinicalTrials.gov Identifier:
    NCT05995743
    Other Study ID Numbers:
    • RECHMPL22_0192
    First Posted:
    Aug 16, 2023
    Last Update Posted:
    Aug 21, 2023
    Last Verified:
    Aug 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by University Hospital, Montpellier
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 21, 2023